Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Andre Goy

Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax Treated CLL in Routine Clinical Practice

Clinical Cancer Research

Cancer Research

Oncology

2019

English

Durable Response With Single-Agent Acalabrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

English

Fibroblast Growth Factor-2 (FGF2) and Syndecan-1 (SDC1) Are Potential Biomarkers for Putative Circulating CD15+/CD30+ Cells in Poor Outcome Hodgkin Lymphoma Patients

Journal of Hematology and Oncology

English

A Patient‐Reported Outcome Instrument to Assess Symptom Burden and Predict Survival in Patients With Advanced Cancer: Flipping the Paradigm to Improve Timing of Palliative and End‐of‐Life Discussions and Reduce Unwanted Health Care Costs

English

Safety and Activity of Ibrutinib in Combination With Durvalumab in Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B‐cell Lymphoma

American Journal of Hematology

Hematology

2019

English

Long-Term Analysis of Phase II Studies of Single-Agent Lenalidomide in Relapsed/Refractory Mantle Cell Lymphoma

American Journal of Hematology

Hematology

2017

English

Addition of Lenalidomide to Rituximab, Ifosfamide, Carboplatin, Etoposide (RICER) in First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

British Journal of Haematology

Hematology

2014

English

T-Rapa6 and T-Rapa12 Cells Differentially Mediate Acute GVHD After Low-Intensity Allogeneic HCT

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2014

English

Protein Calorie Malnutrition, Nutritional Intervention and Personalized Cancer Care

Oncotarget

Oncology

2017

English

A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin-Dependent Kinase Inhibitor, in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Clinical Lymphoma, Myeloma and Leukemia

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Andre Goy

Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax Treated CLL in Routine Clinical Practice

Durable Response With Single-Agent Acalabrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Fibroblast Growth Factor-2 (FGF2) and Syndecan-1 (SDC1) Are Potential Biomarkers for Putative Circulating CD15+/CD30+ Cells in Poor Outcome Hodgkin Lymphoma Patients

A Patient‐Reported Outcome Instrument to Assess Symptom Burden and Predict Survival in Patients With Advanced Cancer: Flipping the Paradigm to Improve Timing of Palliative and End‐of‐Life Discussions and Reduce Unwanted Health Care Costs

Safety and Activity of Ibrutinib in Combination With Durvalumab in Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B‐cell Lymphoma

Long-Term Analysis of Phase II Studies of Single-Agent Lenalidomide in Relapsed/Refractory Mantle Cell Lymphoma

Addition of Lenalidomide to Rituximab, Ifosfamide, Carboplatin, Etoposide (RICER) in First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

T-Rapa6 and T-Rapa12 Cells Differentially Mediate Acute GVHD After Low-Intensity Allogeneic HCT

Protein Calorie Malnutrition, Nutritional Intervention and Personalized Cancer Care

A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin-Dependent Kinase Inhibitor, in Patients With Relapsed or Refractory Mantle Cell Lymphoma